Sign in
Long Term Results of Pro Re Nata Regimen of Aflibercept Treatment in Recurrent or Persistent Neovascular Age-Releated Macular Degeneration
ILKAY KILIC MUFTUOGLU, MD
Annual Meeting Talks
2016
Interim Results and Key Learnings from an Ongoing Phase 2 Study of Encapsulated Cell Therapy Compared to Aflibercept in Patients With Wet AMD
Szilárd Kiss, MD
Genetic Variants Associated With Anti-VEGF Drug Response in Neovascular AMD Patients in the View Trial
Nancy M. Holekamp, MD, FASRS
Updates from the Field
Category: AMD-Neovascular